What is Opus Genetics's granted (in dollars per share)?

Opus Genetics (IRD) reported granted (in dollars per share) of $0.00 in Q1 2026.

What does granted (in dollars per share) mean?

The weighted average fair value at the grant date for equity instruments other than options awarded during the period. This metric provides insight into the cost per unit of equity-based compensation granted to personnel. It helps investors understand the potential dilution impact and the valuation assigned to employee incentives.

Opus Genetics IRD Granted (in dollars per share)

Granted (in dollars per share) at other companies

Alto Ingredients, Inc.ALTO

$1.16-39.3%

CHE

ChemedCHE

514.4-8.8%

Norwood FinancialNWFL

29.6+8.8%

DJT

Trump Media & Technology GroupDJT

$0.00—

Southern First BancsharesSFST

$37.09+1.7%

BeldenBDC

$120.25+33.6%

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's granted (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's granted (in dollars per share)?: Opus Genetics (IRD) reported granted (in dollars per share) of $0.00 in Q1 2026.
What does granted (in dollars per share) mean?: The weighted average fair value at the grant date for equity instruments other than options awarded during the period. This metric provides insight into the cost per unit of equity-based compensation granted to personnel. It helps investors understand the potential dilution impact and the valuation assigned to employee incentives.